Stock Price Updates, Conferences Participations - Research Report on Quest Diagnostics, Pharmacyclics, Health Management Associates, Theravance, and Immunomedics

NEW YORK, December 9, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Quest Diagnostics Inc. (NYSE: DGX), Pharmacyclics Inc. (NASDAQ: PCYC), Health Management Associates Inc. (NYSE: HMA), Theravance Inc. (NASDAQ: THRX), and Immunomedics Inc. (NASDAQ: IMMU). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Quest Diagnostics Inc. Research Report

On December 4, 2013, Quest Diagnostics Inc.'s (Quest Diagnostics) stock declined 0.93%, ending the day's session at $60.86. Over the previous three trading sessions, shares of Quest Diagnostics declined 0.13%, compared to the Dow Jones Industrial Average Index which declined 1.22% during the same period. The Full Research Report on Quest Diagnostics Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/05ba_DGX

--

Pharmacyclics Inc. Research Report

On December 4, 2013, Pharmacyclics Inc.'s (Pharmacyclics) stock declined 1.40%, ending the day's session at $130.38. Over the previous three trading sessions, shares of Pharmacyclics increased 4.71%, compared to the Nasdaq Composite Index which declined 0.54% during the same period. The Full Research Report on Pharmacyclics Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/df74_PCYC

--

Health Management Associates Inc. Research Report

On December 4, 2013, Health Management Associates Inc.'s (Health Management Associates) stock declined 0.30%, ending the day's session at $13.10. Over the previous three trading sessions, shares of Health Management Associates increased 0.08%, compared to the Dow Jones Industrial Average Index which declined 1.22% during the same period. The Full Research Report on Health Management Associates Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/fa70_THRX

--

Theravance Inc. Research Report

On December 4, 2013, Theravance Inc.'s (Theravance) stock increased 0.41%, ending the day's session at $36.92. Over the previous three trading sessions, shares of Theravance declined 2.22%, compared to the Nasdaq Composite Index which declined 0.54% during the same period. The Full Research Report on Theravance Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/fa70_THRX

--

Immunomedics Inc. Research Report

On December 3, 2013, Immunomedics Inc. (Immunomedics) reported that it will participate at the Oppenheimer 24th Annual Healthcare Conference on Tuesday, December 10, 2013 at 10:20 a.m. ET, at the Crowne Plaza Times Square Hotel in New York City. According to the Company, interested parties can access the presentation via the Company website. The Full Research Report on Immunomedics Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/c20d_IMMU

----

EDITOR NOTES:

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
5. For any urgent concerns or inquiries, please contact us at [email protected].
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts' Corner

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED